Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 175

1.

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.

van Vark LC, Bertrand M, Akkerhuis KM, Brugts JJ, Fox K, Mourad JJ, Boersma E.

Eur Heart J. 2012 Aug;33(16):2088-97. doi: 10.1093/eurheartj/ehs075. Epub 2012 Apr 17. Review.

PMID:
22511654
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?

Weir MR.

Clin Ther. 2007 Sep;29(9):1803-24. Review.

PMID:
18035185
[PubMed - indexed for MEDLINE]
3.

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

Li EC, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2014 Aug 22;8:CD009096. doi: 10.1002/14651858.CD009096.pub2. Review.

PMID:
25148386
[PubMed - indexed for MEDLINE]
4.

Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

Werner C, Pöss J, Böhm M.

Drugs. 2010 Jul 9;70(10):1215-30. doi: 10.2165/11537910-000000000-00000. Review.

PMID:
20568830
[PubMed - indexed for MEDLINE]
5.

[Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].

Abassi Z, Armaly Z, Nakhoul F, Hoffman A.

Harefuah. 2008 Jun;147(6):536-42, 573. Review. Hebrew.

PMID:
18693632
[PubMed - indexed for MEDLINE]
6.

The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.

Ferrari R, Boersma E.

Expert Rev Cardiovasc Ther. 2013 Jun;11(6):705-17. doi: 10.1586/erc.13.42. Review.

PMID:
23750680
[PubMed - indexed for MEDLINE]
7.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
[PubMed - indexed for MEDLINE]
8.

Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis.

Tandon P, Abraldes JG, Berzigotti A, Garcia-Pagan JC, Bosch J.

J Hepatol. 2010 Aug;53(2):273-82. doi: 10.1016/j.jhep.2010.03.013. Epub 2010 May 21. Review.

PMID:
20570385
[PubMed - indexed for MEDLINE]
9.

Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Kjeldsen SE, Julius S.

Am Heart J. 2004 Nov;148(5):747-54. Review.

PMID:
15523303
[PubMed - indexed for MEDLINE]
10.

Angiotensin II reactivation and aldosterone escape phenomena in renin-angiotensin-aldosterone system blockade: is oral renin inhibition the solution?

Athyros VG, Mikhailidis DP, Kakafika AI, Tziomalos K, Karagiannis A.

Expert Opin Pharmacother. 2007 Apr;8(5):529-35. Review.

PMID:
17376010
[PubMed - indexed for MEDLINE]
11.

Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Scheen AJ.

Drugs. 2004;64(22):2537-65. Review.

PMID:
15516153
[PubMed - indexed for MEDLINE]
12.

Emerging trends for prevention and treatment of diabetic nephropathy: blockade of the RAAS and BP control.

Hunsicker LG.

J Manag Care Pharm. 2004 Sep;10(5 Suppl A):S12-7. Review.

PMID:
15369420
[PubMed - indexed for MEDLINE]
Free Article
13.

Angiotensin II type 1 receptor blockade: high hopes sent back to reality?

Grothusen A, Divchev D, Luchtefeld M, Schieffer B.

Minerva Cardioangiol. 2009 Dec;57(6):773-85. Review.

PMID:
19942847
[PubMed - indexed for MEDLINE]
14.

[Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].

Abrahám G, Légrády P.

Orv Hetil. 2003 May 4;144(18 Suppl 1):892-5. Review. Hungarian.

PMID:
12785232
[PubMed - indexed for MEDLINE]
16.

Effect of inhibition of the renin-angiotensin system on development of type 2 diabetes mellitus (meta-analysis of randomized trials).

Andraws R, Brown DL.

Am J Cardiol. 2007 Apr 1;99(7):1006-12. Epub 2007 Feb 16.

PMID:
17398202
[PubMed - indexed for MEDLINE]
17.

Discordant responses to two classes of drugs acting on the renin-angiotensin system.

Sever PS, Chang CL.

J Renin Angiotensin Aldosterone Syst. 2001 Mar;2(1):25-30.

PMID:
11881062
[PubMed - indexed for MEDLINE]
18.

Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis.

Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J.

Diabetologia. 2012 Mar;55(3):566-78. doi: 10.1007/s00125-011-2398-8. Epub 2011 Dec 22. Review.

PMID:
22189484
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.

Rao MS.

J Assoc Physicians India. 2010 Feb;58:102-8. Review.

PMID:
20653151
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk